SCHEMBL30686366

SCHEMBL30686366

Cc1nc(C)c(N2CCNC(C)(C)C2)cc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LATS1 O95835 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ AURKA O14965 8/20 0.36
▸ FLT3 P36888 8/20 0.36
▸ AURKB Q96GD4 8/20 0.36
▸ TTR P02766 2/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ CTNNB1 P35222 1/20 0.35
▸ TCF7L2 Q9NQB0 1/20 0.35
▸ PRKD1 Q15139 1/20 0.34
▸ PRKD2 Q9BZL6 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CSNK1E P49674 2/20 0.34
▸ PIM1 P11309 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31368899 0.87 LATS1 (0.39) LATS1PRKCQAURKAFLT3AURKB
SCHEMBL30686350 0.74 LATS1 (0.50) LATS1PRKCQHDAC1MEN1KMT2A
SCHEMBL29643785 0.73 PRKCQ (0.41) LATS1PRKCQAURKAFLT3AURKB
SCHEMBL30686207 0.72 PRKCQ (0.42) LATS1PRKCQAURKAFLT3AURKB
SCHEMBL31368987 0.71 PRKCQ (0.41) LATS1PRKCQAURKAFLT3AURKB
SCHEMBL31369004 0.71 LATS1 (0.38) LATS1PRKCQAURKAFLT3AURKB
SCHEMBL18096106 0.69 PRKCQ (0.42) LATS1PRKCQAURKAFLT3AURKB
SCHEMBL30686213 0.69 KMT2A (0.55) PRKCQTTRHDAC1PRKD1PRKD2
SCHEMBL30686342 0.69 PRKCQ (0.47) PRKCQAURKAFLT3AURKBHDAC1
Hydrochloric Acid SCHEMBL31368999 0.67 MAPT (0.48) PRKCQMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532496-A1 NOVEL PAR-2 INHIBITORS Domain Therapeutics (FR) 2025-04-09 — — EP claimed
WO-2023233033-A1 NOVEL PAR-2 INHIBITORS DOMAIN THERAPEUTICS (FR) 2023-12-07 — — WO claimed
Send feedback